Volume 18 - Issue 9 - September, 2006
Feature
Original Contribution
08/01/2008
Pranab Das, MD, *David J. Moliterno, MD, Richard Charnigo, MD, Debabrata Mukherjee, MD,
Steven R. Steinhubl, MD, J. Darrell Sneed, MD, David C. Booth, MD, Khaled M. Ziada, MD
Pranab Das, MD, *David J. Moliterno,...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have...
08/01/2008
Journal of Invasive Cardiology
Insights
Commentary
08/01/2008
Luis Gruberg, MD and Rafael Beyar, MD, DSc
Luis Gruberg, MD and Rafael Beyar, MD...
Cardiovascular disease is the main cause of death at all stages of chronic renal failure and end-stage renal disease on hemodialysis (ESRD) in adults; it accounts for almost 50% of the mortality of these patients, with an annual mortality...
Cardiovascular disease is the main cause of death at all stages of chronic renal failure and end-stage renal disease on hemodialysis (ESRD) in adults; it accounts for almost 50% of the mortality of these patients, with an annual mortality...
Cardiovascular disease is the...
08/01/2008
Journal of Invasive Cardiology
